Skip to main content
. 2016 Jul 28;2016:7121356. doi: 10.1155/2016/7121356

Figure 1.

Figure 1

Trial profile.  Two patients assigned to the SZ-A group were lost to follow-up (one patient was lost at week 4 after receiving drugs; one patient was lost at week 8 after receiving drugs) because of the failure to getting in contact with them.